​

Disc Medicine (IRON) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

IRON Stock Forecast

Disc Medicine (IRON) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $110.25, with a high of $153.00 and a low of $75.00. This represents a 97.05% increase from the last price of $55.95.

- $40 $80 $120 $160 $200 High: $153 Avg: $110.25 Low: $75 Last Closed Price: $55.95

IRON Stock Rating

Disc Medicine stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 1 Strong Buy (9.09%), 10 Buy (90.91%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 10 1 Strong Sell Sell Hold Buy Strong Buy

IRON Price Target Upside V Benchmarks

TypeNameUpside
StockDisc Medicine97.05%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts5711
Avg Price Target$99.60$105.00$110.91
Last Closing Price$55.95$55.95$55.95
Upside/Downside78.02%87.67%98.23%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 26111---12
Jan, 26112---13
Dec, 25112---13
Nov, 25210---12
Oct, 25210---12
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 17, 2026Wedbush$88.00$60.2845.99%57.28%
Feb 17, 2026Kristen KluskaCantor Fitzgerald$125.00$60.24107.50%123.41%
Feb 17, 2026Morgan Stanley$75.00$60.3924.19%34.05%
Feb 17, 2026Stifel Nicolaus$110.00$61.4379.07%96.60%
Feb 17, 2026Evan SeigermanBMO Capital$100.00$61.4862.65%78.73%
Jan 08, 2026Morgan Stanley$120.00$80.9448.26%114.48%
Dec 08, 2025Martin AusterRaymond James$117.00$96.3221.47%109.12%
Nov 10, 2025Truist Financial$114.00$82.7737.73%103.75%
Oct 17, 2025National Bank$153.00$94.1962.44%173.46%
Oct 17, 2025Raymond James$108.00$74.3645.24%93.03%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 17, 2026Cantor FitzgeraldOverweightOverweighthold
Feb 17, 2026BMO CapitalOutperformOutperformhold
Jan 15, 2026UBSOverweightOverweighthold
Jan 15, 2026WedbushOutperformOutperformhold
Jan 08, 2026Morgan StanleyOverweightOverweighthold
Dec 19, 2025Cowen & Co.BuyBuyhold
Dec 08, 2025Raymond JamesStrong BuyStrong Buyhold
Oct 17, 2025Cantor FitzgeraldOverweightOverweighthold
Oct 17, 2025Raymond JamesStrong BuyStrong Buyhold
Oct 17, 2025WedbushOutperformOutperformhold

Financial Forecast

EPS Forecast

$-10 $-7 $-4 $-1 $2 $5 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.43-----
Avg Forecast$-3.25$-4.13$-5.21$-5.35$-4.12$-0.32
High Forecast$-2.96$-3.94$-4.20$-3.89$2.49$-0.32
Low Forecast$-3.58$-4.50$-6.08$-8.11$-8.83$-0.32
Surprise %5.54%-----

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$6.06M$38.61M$117.86M$308.23M
High Forecast--$6.07M$38.61M$117.86M$308.23M
Low Forecast--$6.04M$38.61M$117.86M$308.23M
Surprise %------

Net Income Forecast

$-200M $-140M $-80M $-20M $40M $100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-76.43M-----
Avg Forecast$-76.43M$-94.10M$-114.74M$-178.09M$-145.87M$-7.04M
High Forecast$-66.05M$-87.87M$-93.71M$-86.87M$55.55M$-7.04M
Low Forecast$-79.93M$-100.32M$-135.76M$-181.01M$-197.16M$-7.04M
Surprise %------

IRON Forecast FAQ

Is Disc Medicine stock a buy?

Disc Medicine stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 10 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Disc Medicine is a favorable investment for most analysts.

What is Disc Medicine's price target?

Disc Medicine's price target, set by 11 Wall Street analysts, averages $110.25 over the next 12 months. The price target range spans from $75 at the low end to $153 at the high end, suggesting a potential 97.05% change from the previous closing price of $55.95.

How does Disc Medicine stock forecast compare to its benchmarks?

Disc Medicine's stock forecast shows a 97.05% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Disc Medicine over the past three months?

  • February 2026: 8.33% Strong Buy, 91.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 7.69% Strong Buy, 92.31% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 7.69% Strong Buy, 92.31% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Disc Medicine’s EPS forecast?

Disc Medicine's average annual EPS forecast for its fiscal year ending in December 2024 is $-4.13, marking a 20.41% increase from the reported $-3.43 in 2023. Estimates for the following years are $-5.21 in 2025, $-5.35 in 2026, $-4.12 in 2027, and $-0.32 in 2028.

What is Disc Medicine’s revenue forecast?

Disc Medicine's average annual revenue forecast for its fiscal year ending in December 2024 is $0, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $6.06M, followed by $38.61M for 2026, $117.86M for 2027, and $308.23M for 2028.

What is Disc Medicine’s net income forecast?

Disc Medicine's net income forecast for the fiscal year ending in December 2024 stands at $-94.095M, representing an 23.11% increase from the reported $-76.429M in 2023. Projections indicate $-115M in 2025, $-178M in 2026, $-146M in 2027, and $-7.041M in 2028.